Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical.
| Autor: | Coyle PK; Department of Neurology, Stony Brook MS Comprehensive Care Center, Baltimore, Maryland, US. Patricia.Coyle@Stonybrookmedicine.edu. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2023 Oct; Vol. 20 (6), pp. 1692-1693. Date of Electronic Publication: 2023 Oct 04. |
| DOI: | 10.1007/s13311-023-01431-y |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink